
1. General Information
MyHep LVIR Tablet is a combination of two direct-acting antiviral medicines, Ledipasvir and Sofosbuvir. It is prescribed for chronic hepatitis C infection and works by targeting proteins required by HCV for viral replication.
It is a prescription medicine, so treatment should be initiated and monitored by a qualified healthcare professional experienced in managing hepatitis C.
2. Product Information
- Brand: MyHep LVIR Tablet
- Active ingredients: Ledipasvir 90 mg + Sofosbuvir 400 mg
- Dosage form: Film-coated tablet
- Typical pack: 28 tablets
- Manufacturer/Marketer: Mylan Pharmaceuticals Pvt. Ltd. / Viatris
- Therapeutic class: Direct-acting antiviral
- Main indication: Chronic hepatitis C virus (HCV) infection
- Route: Oral
- Storage: Store below 30°C and keep according to the manufacturer's storage instructions.
3. Uses of MyHep LVIR Tablet
MyHep LVIR is primarily used for the treatment of chronic hepatitis C infection. Depending on the patient's HCV genotype, liver condition, previous treatment history and other clinical factors, the treatment regimen and duration may differ.
It may be used in appropriate patients with or without compensated cirrhosis, according to the prescribing clinician's assessment.
4. Benefits of MyHep LVIR Tablet
Potential therapeutic benefits include:
- Helps suppress replication of hepatitis C virus.
- Reduces the amount of HCV in the body.
- Supports clearance of HCV when used as part of an appropriate treatment regimen.
- Can help reduce the risk of long-term complications associated with persistent HCV infection.
- Combines two antiviral mechanisms in one tablet, simplifying treatment compared with regimens requiring separate administration of the two active ingredients.
Important: The treatment response depends on factors such as HCV genotype, liver condition, previous treatment and adherence.
5. Side Effects of MyHep LVIR Tablet
Like other medicines, MyHep LVIR may cause side effects. Not everyone experiences them.
Reported adverse effects can include:
- Headache
- Tiredness/fatigue
- Nausea
- Diarrhea
- Dizziness
- Irritability
- Muscle pain
- Skin rash
Some people may experience more serious reactions. Seek medical attention for severe allergic symptoms, significant swelling, breathing difficulty or other unusual symptoms.
6. Common Side Effects
The most commonly reported side effects include:
Headache and tiredness/fatigue.
Other symptoms such as nausea, diarrhea or dizziness can occur in some patients. If symptoms persist, become severe or interfere with daily activities, consult the treating doctor.
7. How to Use MyHep LVIR Tablet
- Take MyHep LVIR exactly as prescribed by your doctor.
- The official prescribing information specifies one tablet once daily for the indicated regimen, although the appropriate treatment duration depends on the patient's clinical circumstances.
- It may be taken with or without food.
- Swallow the tablet whole with water.
- Do not crush, chew or break the tablet unless specifically instructed by a healthcare professional.
- Take it at approximately the same time every day.
- Complete the prescribed course even if you start feeling better.
Do not change the dose or treatment duration without medical advice.
8. How MyHep LVIR Works
MyHep LVIR contains two direct-acting antivirals:
Ledipasvir: inhibits the HCV NS5A protein, which is important for viral replication and assembly.
Sofosbuvir: is converted into an active antiviral form that inhibits the HCV NS5B RNA-dependent RNA polymerase, interfering with viral RNA replication.
By blocking different stages of the HCV life cycle, the combination reduces viral replication and helps the body clear the infection.
9. Safety Advice
Before using MyHep LVIR, inform your doctor about all existing medical conditions and medicines you take.
Important precautions
- Tell your doctor if you have hepatitis B or a history of hepatitis B, as HBV reactivation can occur during or after treatment with direct-acting antivirals.
- Inform your doctor about kidney disease, liver disease, liver transplantation or plans for transplantation.
- Tell your healthcare provider if you are receiving treatment for HIV.
- Drug interactions are important; provide a complete list of prescription medicines, OTC medicines, supplements and herbal products.
- Amiodarone: concomitant use with sofosbuvir-containing regimens can cause serious symptomatic bradycardia and requires particular caution and monitoring.
- Antacids and acid-reducing medicines can affect ledipasvir absorption, so discuss their use with your doctor.
- Pregnancy considerations are particularly important if ribavirin is included in the treatment regimen.
- Avoid self-medication and use only under appropriate medical supervision.
10. FAQs
Q1. What is MyHep LVIR Tablet used for?
It is used to treat chronic hepatitis C virus infection.
Q2. What are the ingredients in MyHep LVIR?
Each tablet contains Ledipasvir 90 mg + Sofosbuvir 400 mg.
Q3. Can MyHep LVIR be taken with food?
Yes. It can generally be taken with or without food.
Q4. How often is MyHep LVIR taken?
The prescribing information specifies one tablet once daily for the relevant regimen; the treatment duration should be determined by the treating physician.
Q5. Can I stop MyHep LVIR when I feel better?
No. Do not stop treatment without consulting your doctor because completing the prescribed antiviral regimen is important.
Q6. Can MyHep LVIR be used with other medicines?
Some medicines can interact with ledipasvir/sofosbuvir. Always provide your doctor with a complete medication list before starting treatment.
Q7. What are the common side effects?
Headache and tiredness are among the commonly reported effects.
Q8. Is MyHep LVIR a prescription medicine?
Yes. It should be used under qualified medical supervision.
11. Substitutes for MyHep LVIR Tablet
Substitutes should only be selected by a healthcare professional after confirming the same active ingredients, strength, dosage form and suitability for the patient's HCV treatment plan.
Examples of products listed as alternatives with the same Ledipasvir 90 mg + Sofosbuvir 400 mg composition include:
- Ledviclear 90 mg/400 mg Tablet
- Ledifos 90 mg/400 mg Tablet
- Ledihep Tablet
- Sofab LP Tablet
- Reclaim-L Tablet
- Hepcvir-L 90 mg/400 mg Tablet
- Resof-L Tablet
- Lesovir 90 mg/400 mg Tablet
- Cimivir L Tablet
Availability and regulatory status can vary by country.
12. SEO Keywords
Primary keywords:
- MyHep LVIR Tablet
- MyHep LVIR 90 mg 400 mg
- MyHep LVIR Tablet exporter
- MyHep LVIR supplier India
- MyHep LVIR medicine exporter
- Ledipasvir 90 mg Sofosbuvir 400 mg
- Ledipasvir Sofosbuvir tablets
- Hepatitis C medicine exporter
- HCV antiviral medicine supplier
- Chronic hepatitis C treatment medicine
B2B / Export SEO keywords:
- Buy MyHep LVIR Tablet from India
- MyHep LVIR Tablet pharmaceutical exporter India
- MyHep LVIR Tablet wholesale supplier
- MyHep LVIR Tablet bulk supplier India
- MyHep LVIR 90/400 mg tablets exporter
- Ledipasvir Sofosbuvir medicine exporter from Nagpur
- Hepatitis C medicines exporter from India
- MyHep LVIR supplier for USA
- MyHep LVIR supplier for UK
- MyHep LVIR supplier for Australia
- MyHep LVIR supplier for Canada
- MyHep LVIR supplier for Singapore
- MyHep LVIR supplier for South Korea
- MyHep LVIR supplier for UAE
- Pharmaceutical medicine exporter from Nagpur India
- Phoenix Exim pharmaceutical exporter
- Phoenix Exim medicine supplier India
- MyHep LVIR bulk pharmaceutical supply
- Ledipasvir Sofosbuvir wholesale exporter
- HCV medicines wholesale supplier India
Keywords







